Login
← Go Back
Kilitch Drugs India
KILITCH · Pharma > Pharmaceuticals & Drugs · MD: Mukund P Mehta · Listing date: Sept. 29, 2010 · Employees: 123 · Mumbai · http://www.kilitch.com
Stock Price vs Company Growth
1d
4.2%
1w
16.4%
1m
10.9%
3m
11.0%
6m
0.9%
1y
22.6%
5y
13.5%
10y
26.3%
all
10.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 164 4.2%
163
208
Company Overview
Sales
237 Cr
Growth: 24.4%
Profit after Tax
30.1 Cr
Growth: -0.4%
Small Cap
573 Cr
P/E: 18.6x
Industry P/E: 31.7x
Fundamentals
Sales (Cr) ₹ 237
Growth 24.4%
EBITDA 15.3%
P/S 2.4x
Dividend 0.0%
P/E 18.6x
Book Value ₹ 80.8
PEG Ratio 0.8x
ROE 12.1%
P/B 2.0x
Shareholding Pattern
Institutions
Dipak Kanayalal Shah
2.65 %
Iepf
1.5 %
Llp
0.05 %
Promoters
Kilitch Company (Pharma) Limited
42.6 %
Bhavin Mukund Mehta
12.87 %
Neeta Mukund Mehta
7.14 %
Mukund Mehta
5.72 %
Others
Increase    Decrease    No change
Company Profile Detailed
Kilitch Drugs is a pharmaceutical company, its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid, liquid and parenteral forms. With nearly two decades of creating safe pharmaceutical solutions and the ultimate purpose of making the world a healthier place.Kilitch is one of the largest manufacturers of antibacterial parenteral formulations. It is also one of the largest producers of sterile liquid formulations in small volumes in India.
Investors (26)
dipak.ka...
dipak.sh...
paresh.p...
Followers (2)
paras5
varsha96